Triheptanoin
Dojolvi (triheptanoin) is a small molecule pharmaceutical. Triheptanoin was first approved as Dojolvi on 2020-06-30. Dojolvi's patent is valid until 2025-10-03 (FDA).
| Trade Name | Dojolvi |
|---|---|
| Common Name | Triheptanoin |
| Indication | |
| Drug Class | Glycerolipids |
